Outpatient IV Insulin Therapy Evidence Doesn't Warrant Coverage, CMS Says
This article was originally published in The Gray Sheet
Executive Summary
Evidence supporting outpatient intravenous insulin therapy as an adjunctive diabetes treatment is insufficient to justify Medicare coverage, CMS says in a Sept. 25 proposed decision memo